Brochure
30 Oct 2021

Corporate Brochure

Download

Murli Krishna Pharma Pvt Ltd is a young and dynamic Novel Drug Delivery Systems (NDDS) organization that provides a range of effective solutions to optimize the delivery of pharmaceutical products. Our current activities include manufacturing of pre-finished formulations i.e. Pellets, Granules and MUPS using Aqueous Based technology, Nano Particles and Transdermal Oil.

Content provided by our supplier

Murli Krishna Pharma Pvt. Ltd.

  • IN
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
Custom Manufacturing/Custom Synthesis
View company profile

Other Content from Murli Krishna Pharma Pvt. Ltd. (5)

  • Company Profile and Product Portfolio

    Brochure Company Profile and Product Portfolio

  • Tamsulosin HCL SR Pellets 0.125%, 0.13%, 0.16%, 0.20%

    Brochure Tamsulosin HCL SR Pellets 0.125%, 0.13%, 0.16%, 0.20%

    Tamsulosin HCL SR pellets is developed using an Aqueous platform and our USP lies in complying with all the US Pharmacoepial specifications. With a formulation that is in line with the Innovator product in terms of release profile, We extensively use Extrusion spheronization process besides the wurster process
  • Nab Paclitaxel (Albumin Bound)

    Video Nab Paclitaxel (Albumin Bound)

    Murli Krishna Pharma is one of the few companies from India who have developed Albumin bound Paclitaxel. The particle size and the encapsulation efficiency have matched with the innovator’s specifications. In Vitro Cell line studies have shown that the activity is comparable to the innovator.
    2020-09-08
  • Orlistat Pellets 50%

    Video Orlistat Pellets 50%

    Leading Manufacturer from India for Orlistat pellets. Offering a product matching the Innovator's release profile, our product does not infringe with the patent.
    2020-09-08
  • Iron & Vitamin Liposomal Transdermal

    Video Iron & Vitamin Liposomal Transdermal

    A Topical administration route had been chosen for the first time for Iron and Vitamins. With Minimal to Zero side effects, the absorption is almost close to 60% when compared to that of the oral route where the absorption is less than 20%. With a strong back up of clinicals on infants, this product of Murli Krishna Pharma is in the process of getting patented
    2020-09-08